Grown Rogue International (GRUSF) Raw Materials (2010 - 2026)
Grown Rogue International (GRUSF) posted quarterly Raw Materials of $730505.0 for Q1 2026, down 29.68% quarter-over-quarter from $1.0 million in Q4 2025.
Grown Rogue International (GRUSF) Raw Materials (2010 - 2026) Analysis & Trends
Grown Rogue International's Raw Materials history runs 5 years deep, the most recent figure standing at $730505.0 for Q1 2026.
- In Q1 2026, Raw Materials changed N/A year-over-year to $730505.0; the TTM figure through Mar 2026 stood at $730505.0 (changed N/A YoY), while the FY2025 annual figure was $1.0 million, up 60.41% from the prior year.
- Raw Materials for Q1 2026 stood at $730505.0, down from $1.0 million in the prior quarter.
- The five-year high for Raw Materials was $1.0 million in Q4 2025, with the low at $647630.0 in Q4 2024.
- The 3-year median for Raw Materials is $730505.0 (2026), against an average of $805670.3.
- Peak annual rise in Raw Materials reached 60.41% in 2025, while the deepest fall reached 60.41% in 2025.
- Grown Rogue International's Raw Materials stood at $647630.0 in 2024, then soared by 60.41% to $1.0 million in 2025, then retreated by 29.68% to $730505.0 in 2026.
- Business Quant data shows GRUSF's Raw Materials at $730505.0 in Q1 2026, $1.0 million in Q4 2025, and $647630.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 449,602.00 |
| Mar 31, 2026 | 730,505.00 |
| Dec 31, 2025 | 1.04 Mn |
| Dec 31, 2024 | 647,630.00 |
| Aug 31, 2011 | 9.16 Mn |
| May 31, 2011 | 8.17 Mn |
| Feb 28, 2011 | 7.74 Mn |
| Nov 30, 2010 | 7.17 Mn |
| Aug 31, 2010 | 5.48 Mn |